The FDA has given its approval for the commercial sale of a soft tissue dermal filler to Anika Therapeutics Inc. Licensed to Galderma Pharma, S.A. This product will be launched globally under the brand name of ELEVESS. Anika had earlier acquired CE Mark certification for this product for commercial sale in the European Union.

Major Benefits
a. It is a corrective and aesthetic dermatology product.
b. It is an injectable soft tissue filler.
c. It can help in the removal of wrinkles and scars.
d. It is based on Anika's proprietary hyaluronic acid technology.
e. It uses the local anesthetic lidocaine.
f. The effects are long lasting.